In RA, new use of JAK inhibitors was associated with nonmelanoma skin cancer vs. TNF inhibitors at 2 y.
Ann Intern Med
; 176(7): JC83, 2023 07.
Article
em En
| MEDLINE
| ID: mdl-37399557
ABSTRACT
SOURCE CITATION Huss V, Bower H, Hellgren K, et al; ARTIS group. Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis a national real-world cohort study. Ann Rheum Dis. 2023;82911-919. 36868796.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Cutâneas
/
Antirreumáticos
/
Inibidores de Janus Quinases
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article